|
|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
| Summaries of Product Characteristics 391 - 420 of 459 |
|
|
|
Package
leaflet | Status for
supply | Name of the medicinal product |
|
PL
|
Resepti
|
Atorvastatin Teva 10 mg, 20 mg, 40 mg, 80 mg tabletti, kalvopäällysteinen SPC 2024-09-13
|
|
PL
|
Resepti
|
Atorvastatin Viatris 10 mg, 20 mg, 40 mg 80 mg tabletti, kalvopäällysteinen SPC 2024-05-20
|
|
PL
|
Resepti
|
Atosiban EVER Pharma 37.5mg-5ml infuusiokonsentraatti-liuosta varten SPC 2020-04-03
|
|
PL
|
Resepti
|
Atosiban EVER Pharma 6.75mg-0.9ml injektioneste-liuos SPC 2020-04-03
|
|
PL
|
Resepti
|
Atosiban EVER Pharma 75mg-10ml infuusiokonsentraatti-liuosta varten SPC 2020-04-03
|
|
|
|
European Medicines Agency's website:
Atosiban SUN - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Atriance - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Atrodual sumutinliuos SPC 2020-01-31
|
|
PL
|
Resepti
|
Atropin 1 mg-ml injektioneste, liuos SPC 2023-02-01
|
|
PL
|
Resepti
|
Atropin Abboxia 0,5 mg-ml, 1 mg-ml injektioneste, liuos, SPC 2024-01-18
|
|
PL
|
Resepti
|
Atropin Aguettant 0.1 mg-ml injektioneste, liuos, esitäytetty ruisku SPC 2022-01-25
|
|
PL
|
Resepti
|
Atropin Aguettant 0.2 mg-ml injektioneste, liuos, esitäytetty ruisku SPC 2022-01-25
|
|
PL
|
Resepti
|
Atropine Accord 0.1 mg-ml injektioneste, liuos, esitäytetty ruisku SPC 2024-05-13
|
|
PL
|
Resepti
|
Atrovent 0.25 mg/ml sumutinliuos SPC 2020-02-11
|
|
PL
|
Resepti
|
Atrovent Comp Eco 20-50 mikrog-annos inhalaatiosumute, liuos SPC 2021-04-23
|
|
PL
|
Resepti
|
Atrovent Comp sumutinliuos SPC 2020-12-17
|
|
PL
|
Resepti
|
Atrovent ECO 20 mikrog/annos inhalaatiosumute, liuos SPC 2021-04-23
|
|
PL
|
Resepti
|
Attadex 5 mg, 10 mg, 20 mg tabletti SPC 2024-09-04
|
|
PL
|
Resepti
|
Attentin 10 mg, 20 mg tabletti SPC 2024-05-22
|
|
PL
|
Resepti
|
Attentin 5 mg tabletti SPC 2022-06-02
|
|
|
|
European Medicines Agency's website:
Aubagio - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Aurorix 150 mg, 300 mg tabletti, kalvopäällysteinen SPC 2023-01-04
|
|
|
|
European Medicines Agency's website:
Avamys - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Avastin - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Avaxim injektioneste, suspensio, esitäytetty ruisku SPC 2021-10-04
|
|
PL
|
Resepti
|
Avelox 400 mg-250 ml infuusioneste, liuos SPC 2020-03-12.docx
|
|
PL
|
Resepti
|
Avitcid 0.025 prosenttinen, 0.05 prosenttinen emulsiovoide SPC 2024-05-02
|
|
PL
|
Resepti
|
Avodart 0.5 mg kapseli, pehmeä, SPC 2023-05-01
|
|
|
|
European Medicines Agency's website:
Avonex - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Avzivi - EMA: EPAR PI
Finnish Swedish
|
|
|
| |
